AIM · Company research

AIM ImmunoTech Inc. (AIM): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

18records availableHealthcare

Stock News & Events data

Database-backed records only

18 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
REG - AIM - AIM Notice - 15/10/2026 - TradingViewREG - AIM - AIM Notice - 15/10/2026 TradingViewView source ↗TradingViewOct 15, 2026neutral00.6
YouGov (AIM:YOU) Stock Revenue Growth Masks A Sharp Profit Squeeze - Simply Wall StreetYouGov (AIM:YOU) Stock Revenue Growth Masks A Sharp Profit Squeeze Simply Wall StreetView source ↗Simply Wall StreetOct 15, 2026neutral00.6
James Halstead (AIM:JHD) Stock Reflects Steady Sales And Thinner Profits - Simply Wall StreetJames Halstead (AIM:JHD) Stock Reflects Steady Sales And Thinner Profits Simply Wall StreetView source ↗Simply Wall StreetOct 15, 2026neutral00.6
Impax Asset Management Group (AIM:IPX) Stock Sees Fair Value Cut After Outflow Driven Reset - Yahoo FinanceImpax Asset Management Group (AIM:IPX) Stock Sees Fair Value Cut After Outflow Driven Reset Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
Roundhouse AI opens retail offer ahead of AIM debut - The Armchair TraderRoundhouse AI opens retail offer ahead of AIM debut The Armchair TraderView source ↗The Armchair TraderOct 9, 2026neutral00.6
Nativo Resources Raises £300,000 Through AIM Share Subscription and Issues Investor Warrants - Yahoo Finance UKNativo Resources Raises £300,000 Through AIM Share Subscription and Issues Investor Warrants Yahoo Finance UKView source ↗Yahoo Finance UKOct 9, 2026neutral00.6
Exploratory data found 34.8 months’ median survival in 39 patients with a low blood-cell ratio. - Stock TitanExploratory data found 34.8 months’ median survival in 39 patients with a low blood-cell ratio. Stock TitanView source ↗Stock TitanOct 7, 2026neutral00.6
REG - AIM - AIM Notice - 07/10/2026 - TradingViewREG - AIM - AIM Notice - 07/10/2026 TradingViewView source ↗TradingViewOct 7, 2026neutral00.6
Vaxcyte Stock Spikes 27% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck - Barron'sVaxcyte Stock Spikes 27% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck Barron'sView source ↗Barron'sOct 5, 2026neutral00.6
AIM ImmunoTech Highlights Media Coverage of Ampligen’s Broad-Spectrum Antiviral Potential and Long COVID IP Expansion - Quiver QuantitativeAIM ImmunoTech Highlights Media Coverage of Ampligen’s Broad-Spectrum Antiviral Potential and Long COVID IP Expansion Quiver QuantitativeView source ↗Quiver QuantitativeOct 5, 2026neutral00.6
An experimental antiviral draws attention for a possible role against Ebola - Stock TitanAn experimental antiviral draws attention for a possible role against Ebola Stock TitanView source ↗Stock TitanOct 5, 2026neutral00.6
Here’s how someone can aim for a million with just a few shares! - The Twelfth MagpieHere’s how someone can aim for a million with just a few shares! The Twelfth MagpieView source ↗The Twelfth MagpieOct 4, 2026neutral00.6
Jet2 (AIM:JET2) Stock Gets Fair Value Bump As Analysts Reassess Growth And Margins - Yahoo FinanceJet2 (AIM:JET2) Stock Gets Fair Value Bump As Analysts Reassess Growth And Margins Yahoo FinanceView source ↗Yahoo FinanceOct 3, 2026neutral00.6
This FTSE AIM stock just jumped 6% on record £51m SpaceX deal - Yahoo Finance UKThis FTSE AIM stock just jumped 6% on record £51m SpaceX deal Yahoo Finance UKView source ↗Yahoo Finance UKOct 1, 2026neutral00.6
With Burry as adviser, a new short-focused fund takes aim at private credit risks - ReutersWith Burry as adviser, a new short-focused fund takes aim at private credit risks ReutersView source ↗ReutersSep 28, 2026neutral00.6
Trick or Treat for AIM to Stock Shelves for Holiday Meals - The Anderson ObserverTrick or Treat for AIM to Stock Shelves for Holiday Meals The Anderson ObserverView source ↗The Anderson ObserverSep 28, 2026neutral00.6
GOP takes aim at Congress’ next ‘get filthy rich’ loophole after stock-trading ban - Congresswoman Young Kim (.gov)GOP takes aim at Congress’ next ‘get filthy rich’ loophole after stock-trading ban Congresswoman Young Kim (.gov)View source ↗Congresswoman Young Kim (.gov)Sep 25, 2026neutral00.6
AIM Stock Soars 42% As Pancreatic Cancer Trial Hits Key Enrollment Milestone Before Schedule — CEO Sees 'Significant Value-Inflection Period' Ahead - StocktwitsAIM Stock Soars 42% As Pancreatic Cancer Trial Hits Key Enrollment Milestone Before Schedule — CEO Sees 'Significant Value-Inflection Period' Ahead StocktwitsView source ↗StocktwitsJun 1, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.